BioLineRx Reports Publication of Positive Phase 1/2 Results in Stem Cell ... - Benzinga

BioLineRx Reports Publication of Positive Phase 1/2 Results in Stem Cell BenzingaBioLineRx (NASDAQ: BLRX) announced today the publication of results showing that BL-8040 (formerly known as BKT-140) enables the efficient mobilization of stem cells from the bone marrow into the peripheral blood, thus facilitating autologous stem cell and more read more

http://blog.zandcell.com/biolinerx-reports-publication-of-positive-phase-12-results-in-stem-cell-benzinga/?utm_source=rss&utm_medium=rss&utm_campaign=biolinerx-reports-publication-of-positive-phase-12-results-in-stem-cell-benzinga